packageReteplase

reteplase

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Reteplase is a fibrinolytic (plasminogen-activating) drug that was used to treat myocardial infarction. Its products have been withdrawn from the European Union market, so it is no longer authorised there.

Summary written by glm-5.3-flash from Wikidata Q3933703 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:reteplase
ATC codes:B01AD07
DrugBank:DB00015
Wikidata:Q3933703
molar mass:39589.6 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown